Schizoaffective Disorders Completed Phase 3 Trials for Aripiprazole (DB01238)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00036361Broad Effectiveness: Study With AripiprazoleTreatment
NCT00095524Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective DisorderTreatment
NCT00283179Aripiprazole in the Treatment of Acutely Relapsed Patients With SchizophreniaTreatment